Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy.
APRIL
IgA nephropathy
immunoglobulin repertoire sequencing
microbiome
tonsillectomy
Journal
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402
Informations de publication
Date de publication:
01 01 2021
01 01 2021
Historique:
received:
22
01
2020
pubmed:
26
10
2020
medline:
19
3
2021
entrez:
25
10
2020
Statut:
ppublish
Résumé
Immunoglobulin A nephropathy (IgAN) is the most common glomerulonephritis worldwide, characterized by mesangial polymeric IgA1 deposition. IgAN is believed to develop owing to aberrant mucosal immunoreaction against commensals in the tonsils. However, the exact interrelation between pathogenic IgA and mucosal microbiota in IgAN patients is unclear. Biopsy-proven IgAN or recurrent tonsillitis (RT) patients who had undergone tonsillectomy were enrolled. We used 16S ribosomal RNA gene amplicon sequencing with a flow cytometry-based bacterial cell sorting technique) and immunoglobulin repertoire sequencing of the IgA heavy chain to characterize IgA-coated bacteria of the tonsillar microbiota (IgA-SEQ) and their corresponding IgA repertoire. Furthermore, we fractionated patient serum using gel-filtration chromatography and performed flow cytometry-based analysis of IgA binding to bacteria cultured from incised tonsils. Tonsillar proliferation-inducing ligand and B-cell activating factor levels were significantly higher in IgAN than in RT patients. IgA-SEQ for tonsillar microbiota revealed the preferential binding ability of IgA to Bacteroidetes in IgAN tonsils compared with those from RT patients. Expression of immunoglobulin heavy (IGH) constant alpha 1 with IGH variable 3-30 was significantly higher in IgAN than that in RT, and positively correlated with the IgA-coated enrichment score of Bacteroidetes. Serum polymeric IgA, comprising high levels of GdIgA1, exhibited considerable binding to Bacteroidetes strains cultured from the tonsils of IgAN patients. These findings provide evidence that aberrant mucosal immune responses to tonsillar anaerobic microbiota, primarily consisting of members of the phylum Bacteroidetes, are involved in IgAN pathophysiology.
Sections du résumé
BACKGROUND
Immunoglobulin A nephropathy (IgAN) is the most common glomerulonephritis worldwide, characterized by mesangial polymeric IgA1 deposition. IgAN is believed to develop owing to aberrant mucosal immunoreaction against commensals in the tonsils. However, the exact interrelation between pathogenic IgA and mucosal microbiota in IgAN patients is unclear.
METHODS
Biopsy-proven IgAN or recurrent tonsillitis (RT) patients who had undergone tonsillectomy were enrolled. We used 16S ribosomal RNA gene amplicon sequencing with a flow cytometry-based bacterial cell sorting technique) and immunoglobulin repertoire sequencing of the IgA heavy chain to characterize IgA-coated bacteria of the tonsillar microbiota (IgA-SEQ) and their corresponding IgA repertoire. Furthermore, we fractionated patient serum using gel-filtration chromatography and performed flow cytometry-based analysis of IgA binding to bacteria cultured from incised tonsils.
RESULTS
Tonsillar proliferation-inducing ligand and B-cell activating factor levels were significantly higher in IgAN than in RT patients. IgA-SEQ for tonsillar microbiota revealed the preferential binding ability of IgA to Bacteroidetes in IgAN tonsils compared with those from RT patients. Expression of immunoglobulin heavy (IGH) constant alpha 1 with IGH variable 3-30 was significantly higher in IgAN than that in RT, and positively correlated with the IgA-coated enrichment score of Bacteroidetes. Serum polymeric IgA, comprising high levels of GdIgA1, exhibited considerable binding to Bacteroidetes strains cultured from the tonsils of IgAN patients.
CONCLUSIONS
These findings provide evidence that aberrant mucosal immune responses to tonsillar anaerobic microbiota, primarily consisting of members of the phylum Bacteroidetes, are involved in IgAN pathophysiology.
Identifiants
pubmed: 33099625
pii: 5939792
doi: 10.1093/ndt/gfaa223
pmc: PMC7771982
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
75-86Commentaires et corrections
Type : ErratumIn
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA.
Références
Kidney Int. 2002 Aug;62(2):465-75
pubmed: 12110007
J Am Soc Nephrol. 2011 Oct;22(10):1795-803
pubmed: 21949093
Annu Rev Genet. 2011;45:167-202
pubmed: 21854230
Nature. 2000 Dec 7;408(6813):740-5
pubmed: 11130078
Nephrol Dial Transplant. 2017 Dec 1;32(12):2072-2079
pubmed: 27683270
Anat Rec (Hoboken). 2013 Mar;296(3):378-81
pubmed: 23382140
Nature. 2016 Jul 06;535(7610):75-84
pubmed: 27383982
Int J Pediatr Otorhinolaryngol. 2005 Jan;69(1):9-19
pubmed: 15627441
Cell. 2000 Sep 1;102(5):553-63
pubmed: 11007474
Science. 2009 Jul 31;325(5940):617-20
pubmed: 19644121
Nephrol Dial Transplant. 2019 Jul 1;34(7):1135-1144
pubmed: 30462346
J Am Soc Nephrol. 2004 Mar;15(3):622-34
pubmed: 14978164
Nat Immunol. 2002 Sep;3(9):822-9
pubmed: 12154359
JAMA Netw Open. 2019 May 3;2(5):e194772
pubmed: 31150076
Nephrol Dial Transplant. 2006 Sep;21(9):2478-84
pubmed: 16757497
Nat Genet. 2014 Nov;46(11):1187-96
pubmed: 25305756
J Am Soc Nephrol. 2016 Sep;27(9):2748-61
pubmed: 26825533
Front Immunol. 2017 May 03;8:389
pubmed: 28515723
Nat Genet. 2011 Dec 25;44(2):178-82
pubmed: 22197929
Front Immunol. 2018 Apr 03;9:668
pubmed: 29666626
J Bacteriol. 1991 Jan;173(2):697-703
pubmed: 1987160
Mucosal Immunol. 2015 Jan;8(1):176-85
pubmed: 24962092
J Med Syst. 2012 Aug;36(4):2621-31
pubmed: 21584771
Nephrol Dial Transplant. 2015 Aug;30(8):1315-21
pubmed: 26109484
J Exp Med. 2018 May 7;215(5):1397-1415
pubmed: 29588346
J Am Soc Nephrol. 2008 Dec;19(12):2384-95
pubmed: 18776126
J Am Soc Nephrol. 2008 May;19(5):1008-14
pubmed: 18272841
Kidney Int. 2007 Jun;71(11):1148-54
pubmed: 17342176
Immunity. 2015 Sep 15;43(3):541-53
pubmed: 26320660
J Immunol. 2015 Aug 15;195(4):1417-26
pubmed: 26150533
Nat Rev Rheumatol. 2014 Jun;10(6):365-73
pubmed: 24614588
Immunity. 2007 Jun;26(6):812-26
pubmed: 17570691
Sci Transl Med. 2015 Feb 25;7(276):276ra24
pubmed: 25717097
Cell. 2014 Aug 28;158(5):1000-1010
pubmed: 25171403
N Engl J Med. 2013 Jun 20;368(25):2402-14
pubmed: 23782179
Am J Kidney Dis. 2001 Oct;38(4):736-43
pubmed: 11576876
J Am Soc Nephrol. 2017 Apr;28(4):1227-1238
pubmed: 27920152
Immunity. 2011 Feb 25;34(2):247-57
pubmed: 21333555
J Clin Invest. 2014 Jun;124(6):2325-32
pubmed: 24892706
Annu Rev Immunol. 2010;28:243-73
pubmed: 20192805
Sci Transl Med. 2017 Feb 8;9(376):
pubmed: 28179509
Kidney Int. 2001 Mar;59(3):1077-85
pubmed: 11231363
J Clin Invest. 2011 Oct;121(10):3991-4002
pubmed: 21881212
Nature. 1974 Nov 29;252(5482):418-20
pubmed: 4215033